No Data
No Data
Zhejiang Dayang Biotech Group (003017.SZ): The employee stock ownership plan for 2024 has been completed without any trade transfers.
On September 10, GeLongHui reported that on September 10, 2024, Zhejiang Dayang Biotech Group (003017.SZ) announced that the company had received a "Securities Transfer Registration Confirmation" issued by the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited, stating that 1,947,030 shares of the company's stocks held by the "Special Securities Account for Repurchase of Zhejiang Dayang Biotech Group Co., Ltd." had been transferred off-market to the "Zhejiang Dayang Biotech Group Co., Ltd.-2024 Employee Stock Ownership Plan" account on September 9, 2024. The transferred shares account for 2.32% of the total share capital of the company. This employee stock ownership plan was implemented through a non-h
Ocean Life: 2024 Semi-Annual Report Summary
Ocean Life: 2024 Semi-Annual Report
Zhejiang Dayang Biotech Group (003017.SZ): The net income for the first half of the year was 314.363 million yuan, an increase of 31.77% year-on-year.
Gelonghui August 26th | Zhejiang Dayang Biotech Group (003017.SZ) released the 2024 interim report, with revenue of 0.437 billion yuan during the reporting period, a decrease of 9.23% year-on-year; net income attributable to shareholders of the listed company was 31.4363 million yuan, an increase of 31.77% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.0902 million yuan, an increase of 47.43% year-on-year; basic earnings per share was 0.3857 yuan.
Zhejiang Dayang Biotech Group (003017.SZ): has repurchased 3.23% of the shares.
Zhejiang Dayang Biotech Group (003017.SZ) announced on August 1st that as of July 31st, 2024, the company had repurchased a total of 2,716,000 shares through a repurchase special securities account by means of centralized bidding trading, accounting for 3.2333% of the total share capital of the company. The highest fill price was 17.50 yuan/share, and the lowest fill price was 12.61 yuan/share, with a total transaction amount of 41.9555 million yuan (excluding transaction fees).
Zhejiang Dayang Biotech Group (003017.SZ) plans to launch an employee stock ownership plan in 2024, with a stock scale not exceeding 1.947 million shares.
Zhejiang Dayang Biotech Group (003017.SZ) has released the draft of the employee stock ownership plan for 2024, in which employees can participate...
No Data
No Data